|
1
|
Corsten MF, Schroen B and Heymans S:
Inflammation in viral myocarditis: Friend or foe? Trends Mol Med.
18:426–437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sagar S, Liu PP and Cooper LT Jr:
Myocarditis. Lancet. 379:738–747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dennert R, Crijns HJ and Heymans S: Acute
viral myocarditis. Eur Heart J. 29:2073–2082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blauwet LA and Cooper LT: Myocarditis.
Prog Cardiovasc Dis. 52:274–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esfandiarei M and McManus BM: Molecular
biology and pathogenesis of viral myocarditis. Annu Rev Pathol.
3:127–155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shauer A, Gotsman I, Keren A, Zwas DR,
Hellman Y, Durst R and Admon D: Acute viral myocarditis: Current
concepts in diagnosis and treatment. Isr Med Assoc J. 15:180–185.
2013.PubMed/NCBI
|
|
7
|
Liu Y, Liang RM, Ma QP, Xu K, Liang XY,
Huang W, Sutton R, Ding J, O'Neil PM and Cheng CR: Synthesis of
thioether andrographolide derivatives and their inhibitory effect
against cancer cells. MedChemComm. 8:1268–1274. 2017. View Article : Google Scholar
|
|
8
|
Ding L, Li J, Song B, Xiao X, Huang W,
Zhang B, Tang X, Qi M, Yang Q, Yang Q, et al: Andrographolide
prevents high-fat diet-induced obesity in C57BL/6 mice by
suppressing the sterol regulatory element-binding protein pathway.
J Pharmacol Exp Ther. 351:474–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen HW, Huang CS, Li CC, Lin AH, Huang
YJ, Wang TS, Yao HT and Lii CK: Bioavailability of andrographolide
and protection against carbon tetrachloride-induced oxidative
damage in rats. Toxicol Appl Pharmacol. 280:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan WSD, Liao W, Zhou S and Wong WSF: Is
there a future for andrographolide to be an anti-inflammatory drug?
Deciphering its major mechanisms of action. Biochem Pharmacol.
139:71–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Zhu D, Wang Y and Ju Y:
Andrographolide attenuates LPS-induced cardiac malfunctions through
inhibition of IκB phosphorylation and apoptosis in mice. Cell
Physiol Biochem. 37:1619–1628. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu RH, Jacob JR and Tennant B:
Andrographolide derivatives to treat viral infections: U.S. Patent
8445,533 (P). 2013.
|
|
13
|
Weller AH, Simpson K, Herzum M, Van Houten
N and Huber SA: Coxsackievirus-B3-induced myocarditis: Virus
receptor antibodies modulate myocarditis. J Immunol. 143:1843–1850.
1989.PubMed/NCBI
|
|
14
|
Jayakumar T, Hsieh CY, Lee JJ and Sheu JR:
Experimental and clinical pharmacology of andrographis paniculata
and its major bioactive phytoconstituent andrographolide. Evid
Based Complement Alternat Med. 2013:8467402013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wintachai P, Kaur P, Lee RC, Ramphan S,
Kuadkitkan A, Wikan N, Ubol S, Roytrakul S, Chu JJ and Smith DR:
Activity of andrographolide against chikungunya virus infection.
Sci Rep. 5:141792015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ekalaksananan T, Sookmai W, Fangkham S,
Pientong C, Aromdee C, Seubsasana S and Kongyingyoes B: Activity of
andrographolide and its derivatives on HPV16 pseudovirus infection
and viral oncogene expression in cervical carcinoma cells. Nutr
Cancer. 67:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JC, Tseng CK, Young KC, Sun HY, Wang
SW, Chen WC, Lin CK and Wu YH: Andrographolide exerts
anti-hepatitis C virus activity by up-regulating haeme oxygenase-1
via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Br J
Pharmacol. 171:237–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Becher PM, Gotzhein F, Klingel K, Escher
F, Blankenberg S, Westermann D and Lindner D: Cardiac function
remains impaired despite reversible cardiac remodeling after acute
experimental viral myocarditis. J Immunol Res. 2017:65906092017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang D, Li T, Cui H and Zhang Y: Analysis
of the indicating value of cardiac troponin i, tumor necrosis
factor-α, interleukin-18, Mir-1 and Mir-146b for viral myocarditis
among children. Cell Physiol Biochem. 40:1325–1333. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hutchins AP, Diez D and Miranda-Saavedra
D: The IL-10/STAT3-mediated anti-inflammatory response: Recent
developments and future challenges. Brief Funct Genomics.
12:489–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roffê E, Rothfuchs AG, Santiago HC, Marino
AP, Ribeiro-Gomes FL, Eckhaus M, Antonelli LR and Murphy PM: IL-10
limits parasite burden and protects against fatal myocarditis in a
mouse model of Trypanosoma cruzi infection. J Immunol. 188:649–660.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maier HJ, Schips TG, Wietelmann A, Krüger
M, Brunner C, Sauter M, Klingel K, Böttger T, Braun T and Wirth T:
Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces
reversible inflammatory cardiomyopathy and heart failure. Proc Natl
Acad Sci USA. 109:11794–11799. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Valaperti A: Drugs targeting the canonical
NF-κB pathway to treat viral and autoimmune myocarditis. Curr Pharm
Des. 22:440–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hyam SR, Lee IA, Gu W, Kim KA, Jeong JJ,
Jang SE, Han MJ and Kim DH: Arctigenin ameliorates inflammation in
vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing
M1 macrophages to M2-like macrophages. Eur J Pharmacol. 708:21–29.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han W, Xiong Y, Li Y, Fang W, Ma Y, Liu L,
Li F and Zhu X: Anti-arthritic effects of clematichinenoside (AR-6)
on PI3K/Akt signaling pathway and TNF-α associated with
collagen-induced arthritis. Pharm Biol. 51:13–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
